PCH
TEVA icon

Polar Capital Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Polar Capital Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177M Buy
5,212,749
+37,691
+0.7% +$1.26M 0.42% 56
2026
Q1 		$156M Buy
5,175,058
+187,368
+4% +$6.03M 0.55% 44
2025
Q4 		$156M Buy
4,987,690
+978,608
+24% +$24.1M 0.6% 48
2025
Q3 		$81M Buy
+4,009,082
New +$70.4M 0.39% 72

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Polar Capital Holdings's TEVA Position: Q2 2026 in Review

Polar Capital Holdings increased its Teva Pharmaceuticals (TEVA) stake by 0.73% in Q2 2026, buying an estimated $1.26M and bringing the position to 5,212,749 shares worth $177M. The position accounts for 0.42% of the portfolio, ranked #56.

Polar Capital Holdings first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Polar Capital Holdings held 5,212,749 shares of Teva Pharmaceuticals worth $177M as of Q2 2026.
  • Polar Capital Holdings bought 37,691 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.26M.
  • Teva Pharmaceuticals made up 0.42% of Polar Capital Holdings's portfolio in Q2 2026, its #56 holding.
  • Polar Capital Holdings first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.